+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Glucokinase Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Glucokinase Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Papillary Thyroid Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Papillary Thyroid Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pancreatic Endocrine Tumor - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatic Endocrine Tumor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pancreatic Ductal Adenocarcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatic Ductal Adenocarcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 200 Pages
  • Global
From
Malignant Mesothelioma - Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Mesothelioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 110 Pages
  • Global
From
Kaposi's Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Kaposi's Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Thyroid Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Thyroid Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Thymus Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Thymus Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Liposarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Liposarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Somatostatin Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Somatostatin Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD33 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD33 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD3 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD3 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Anti-CD28 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD28 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Anti-CD19 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD19 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD152 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD152 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti GM-CSF Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti GM-CSF Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Metastatic Prostate Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Prostate Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Hepcidin Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Hepcidin Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more